BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...
NanoViricides has secured orphan drug designation from the European Medicines Agency (EMA) for its drug candidate DengueCide, for the treatment of dengue and dengue hemorrhagic fever. Dengue fever is a mosquito-borne disease that affects ...
Tags: Nanoviricides Drug
Canada-based Titan Medical has recently commenced tissue testing that was successful in assessing and measuring the functionality of the SPORT (single port orifice robotic technology) surgical system. The company will perform a sequence ...
Corgenix Medical, a developer of diagnostic test kits, has filed pre-market notification with the US Food and Drug Administration under Section 510(k) of the US Federal Food, Drug and Cosmetic Act for its hyaluronic acid (HA) enzyme-linked ...
Tags: Corgenix Medical
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
Skyline Medical, formerly BioDrain Medical, has made new enhancements to its flagship product STREAMWAY system. The US Food and Drug Administration approved STREAMWAY system is designed to improve safety and efficiency in the operating ...
Tags: Skyline Medical, Streamway System
Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...
Tags: Helsinn group, Pharma Marketing
Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, has announced that the US Food and Drug Administration (FDA) has cleared the company's investigational new drug ...
Tags: Discovery Labs, Medicine
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
Lupin Pharmaceuticals (LPI), a US subsidiary of India-based Lupin, has launched its generic Rabeprazole Sodium delayed-release tablets, 20mg. Earlier, the company had received final approval from the US Food and Drug Administration (FDA) ...
Tags: Lupin Pharma, tablets
Israeli bio-medical engineering company ITGI Medical has signed a strategic cooperation agreement with Vascular Solutions, a medical device company, to commercialize ITGI's Aneugraft Dx coronary covered stent in the US market. Pursuant to ...
Tags: ITGI Medical, Aneugraft DX Stent
Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...
Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, has announced the availability of its ENSEAL G2 articulating tissue sealer in the US. Ethicon Endo-Surgery claims ENSEAL G2 is the first and only articulating advanced energy device ...
Tags: Ethicon Endo-Surgery
The Netherlands-based Royal DSM has announced a partnership with US-based BiO2 Medical to supply DSM’s proprietary ComfortCoat lubricious coating and its coating application expertise for use in BiO2 Medical’s Angel catheter. ...
US-based AngioScore has presented six-month clinical and quantitative coronary angiography results from the first-in-human (FIH) clinical trial of its drug-coated AngioSculpt PTCA scoring balloon catheter at the Transcatheter Cardiovascular ...
Tags: AngioScore, Balloon Catheter